Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.

Combinations of beta-lactams plus aminoglycosides have been standard therapy for suspected infections in granulocytopenic cancer patients, especially those with profound long-lasting granulocytopenia. With the advent of new broad-spectrum bactericidal antibiotics such as extended-spectrum cephalospo...

Descripció completa

Guardat en:

Dades bibliogràfiques
Publicat a:	Antimicrob Agents Chemother
Autors principals:	Cometta, A, Calandra, T, Gaya, H, Zinner, S H, de Bock, R, Del Favero, A, Bucaneve, G, Crokaert, F, Kern, W V, Klastersky, J, Langenaeken, I, Micozzi, A, Padmos, A, Paesmans, M, Viscoli, C, Glauser, M P
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1996
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163274/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723449/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1108
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars